Eastern Capital Ltd - Net Worth and Insider Trading

Eastern Capital Ltd Net Worth

The estimated net worth of Eastern Capital Ltd is at least $140 Million dollars as of 2024-12-27. Eastern Capital Ltd is the 10% Owner of Cytokinetics Inc and owns about 2,383,850 shares of Cytokinetics Inc (CYTK) stock worth over $116 Million. Eastern Capital Ltd is the 10% Owner of Vericel Corp and owns about 424,988 shares of Vericel Corp (VCEL) stock worth over $25 Million. Eastern Capital Ltd is also the 10% Owner of iBio Inc and owns about 17,259 shares of iBio Inc (IBIO) stock worth over $41,594. Besides these, Eastern Capital Ltd also holds Cyclacel Pharmaceuticals Inc (CYCC) . Details can be seen in Eastern Capital Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eastern Capital Ltd has not made any transactions after 2020-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eastern Capital Ltd

To

Eastern Capital Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eastern Capital Ltd owns 6 companies in total, including iBio Inc (IBIO) , Marker Therapeutics Inc (MRKR) , and Cyclacel Pharmaceuticals Inc (CYCC) among others .

Click here to see the complete history of Eastern Capital Ltd’s form 4 insider trades.

Insider Ownership Summary of Eastern Capital Ltd

Ticker Comapny Transaction Date Type of Owner
IBIO iBio Inc 2020-08-11 10 percent owner
MRKR Marker Therapeutics Inc 2015-03-09 10 percent owner
CYCC Cyclacel Pharmaceuticals Inc 2017-07-19 10 percent owner
LIMIT LIMIT 2015-10-30 10 percent owner
LIMIT LIMIT 2013-08-16 10 percent owner
LIMIT LIMIT 2012-06-20 10 percent owner

Eastern Capital Ltd Latest Holdings Summary

Eastern Capital Ltd currently owns a total of 4 stocks. Among these stocks, Eastern Capital Ltd owns 2,383,850 shares of Cytokinetics Inc (CYTK) as of June 20, 2012, with a value of $116 Million and a weighting of 82.5%. Eastern Capital Ltd owns 424,988 shares of Vericel Corp (VCEL) as of August 16, 2013, with a value of $25 Million and a weighting of 17.47%. Eastern Capital Ltd also owns 17,259 shares of iBio Inc (IBIO) as of August 11, 2020, with a value of $41,594 and a weighting of 0.03%. The other 1 stocks Cyclacel Pharmaceuticals Inc (CYCC) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Eastern Capital Ltd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTK Cytokinetics Inc 2012-06-20 2,383,850 48.54 115,712,079
VCEL Vericel Corp 2013-08-16 424,988 57.67 24,509,058
IBIO iBio Inc 2020-08-11 17,259 2.41 41,594
CYCC Cyclacel Pharmaceuticals Inc 2017-07-19 7,224 0.32 2,343

Holding Weightings of Eastern Capital Ltd


Eastern Capital Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Eastern Capital Ltd has made a total of 0 transactions in Cytokinetics Inc (CYTK) over the past 5 years. The most-recent trade in Cytokinetics Inc is the sale of 0 shares on June 20, 2012, which brought Eastern Capital Ltd around $0.

According to the SEC Form 4 filings, Eastern Capital Ltd has made a total of 0 transactions in Vericel Corp (VCEL) over the past 5 years. The most-recent trade in Vericel Corp is the sale of 0 shares on August 16, 2013, which brought Eastern Capital Ltd around $0.

According to the SEC Form 4 filings, Eastern Capital Ltd has made a total of 2 transactions in iBio Inc (IBIO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in iBio Inc is the sale of 48,970 shares on August 11, 2020, which brought Eastern Capital Ltd around $80 Million.

More details on Eastern Capital Ltd's insider transactions can be found in the Insider Trading History of Eastern Capital Ltd table.

Insider Trading History of Eastern Capital Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eastern Capital Ltd Trading Performance

GuruFocus tracks the stock performance after each of Eastern Capital Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eastern Capital Ltd is 6.73%. GuruFocus also compares Eastern Capital Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eastern Capital Ltd within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eastern Capital Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eastern Capital Ltd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.16 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Eastern Capital Ltd Ownership Network

Ownership Network List of Eastern Capital Ltd

No Data

Ownership Network Relation of Eastern Capital Ltd

Insider Network Chart

Eastern Capital Ltd Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

Eastern Capital Ltd is the 10 percent owner of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, Eastern Capital Ltd made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 66,694 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,335 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,335 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

iBio Inc Insider Transactions

No Available Data

Eastern Capital Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Eastern Capital Ltd. You might contact Eastern Capital Ltd via mailing address: 10 Market Street, #773, Camana Bay, Grand Cayman E9 Ky1-9006.

Discussions on Eastern Capital Ltd

No discussions yet.